-
EP3972603
European procedure
Extract from the Register of European Patents
EP About this file: EP3972603
| EP3972603 - METHODS OF TREATING SJÖGREN'S SYNDROME USING A BRUTON'S TYROSINE KINASE INHIBITOR [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 02.08.2024 Database last updated on 03.05.2025 | |
| Former | Grant of patent is intended Status updated on 01.04.2024 | ||
| Former | Request for examination was made Status updated on 25.02.2022 | ||
| Former | The international publication has been made Status updated on 27.11.2020 | ||
| Former | unknown Status updated on 08.06.2020 | Most recent event Tooltip | 18.04.2025 | Lapse of the patent in a contracting state | published on 21.05.2025 [2025/21] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2022/13] | Inventor(s) | 01 /
BHATTACHARYA, Souvik Novartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139 / US | 02 /
BIETH, Bruno Novartis Pharma AG Postfach 4002 Basel / CH | 03 /
CABANSKI, Maciej Novartis Pharma AG Postfach 4002 Basel / CH | 04 /
CENNI, Bruno Novartis Pharma AG Postfach Novartis Institutes for Biomed. Research 4002 Basel / CH | 05 /
DE BUCK, Stefan Novartis Pharma AG Postfach 4002 Basel / CH | 06 /
KAUL, Martin Novartis Pharma AG Postfach Novartis Institutes for Biomed. Research 4002 Basel / CH | 07 /
KINHIKAR, Arvind Novartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139 / US | 08 /
RADIVOJEVIC, Andrijana Novartis Pharmaceuticals Corporation 1 Health Plaza East Hanover, New Jersey 07936 / US | 09 /
VITALITI GARAMI, Alessandra Novartis Pharma AG Postfach 4002 Basel / CH | [2022/13] | Representative(s) | Thompson, Sarah Louise Novartis Pharma AG Patent Department Lichtstrasse 35 4056 Basel / CH | [N/P] |
| Former [2022/13] | Thompson, Sarah Louise Novartis Pharma AG Postfach 4002 Basel / CH | Application number, filing date | 20729203.8 | 20.05.2020 | [2022/13] | WO2020IB54754 | Priority number, date | US201962851994P | 23.05.2019 Original published format: US 201962851994 P | [2022/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020234781 | Date: | 26.11.2020 | Language: | EN | [2020/48] | Type: | A1 Application with search report | No.: | EP3972603 | Date: | 30.03.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.11.2020 takes the place of the publication of the European patent application. | [2022/13] | Type: | B1 Patent specification | No.: | EP3972603 | Date: | 04.09.2024 | Language: | EN | [2024/36] | Search report(s) | International search report - published on: | EP | 26.11.2020 | Classification | IPC: | A61K31/505, A61P37/00 | [2022/13] | CPC: |
A61K31/505 (EP,IL,US);
A61K31/513 (KR);
A61P1/02 (US);
A61P37/00 (EP,KR);
A61P37/06 (US);
C07D239/47 (KR)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/13] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | METHODEN ZUR BEHANDLUNG VON SJÖGREN-SYNDROM MIT EINEM HEMMER VON BRUTON-KINASE | [2024/16] | English: | METHODS OF TREATING SJÖGREN'S SYNDROME USING A BRUTON'S TYROSINE KINASE INHIBITOR | [2022/13] | French: | MÉTHODES DE TRAITEMENT DU SYNDROME DE SJÖGREN UTILISANT UN INHIBITEUR DE LA KINASE DE BRUTON | [2024/16] |
| Former [2022/13] | VERFAHREN ZUR BEHANDLUNG VON SJÖGREN-SYNDROM UNTER VERWENDUNG EINES BRUTON-TYROSIN-KINASE-INHIBITORS | ||
| Former [2022/13] | MÉTHODES DE TRAITEMENT DU SYNDROME DE SJÖGREN À L'AIDE D'UN INHIBITEUR DE LA TYROSINE KINASE DE BRUTON | Entry into regional phase | 23.12.2021 | National basic fee paid | 23.12.2021 | Designation fee(s) paid | 23.12.2021 | Examination fee paid | Examination procedure | 23.12.2021 | Examination requested [2022/13] | 23.12.2021 | Date on which the examining division has become responsible | 12.07.2022 | Amendment by applicant (claims and/or description) | 02.04.2024 | Communication of intention to grant the patent | 26.07.2024 | Fee for grant paid | 26.07.2024 | Fee for publishing/printing paid | 26.07.2024 | Receipt of the translation of the claim(s) | Divisional application(s) | EP24191253.4 / EP4442321 | Fees paid | Renewal fee | 26.04.2022 | Renewal fee patent year 03 | 27.04.2023 | Renewal fee patent year 04 | 26.04.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 04.09.2024 | [2025/21] | Cited in | International search | [YD]WO2015079417 (NOVARTIS AG [CH], et al); | [Y]WO2017106429 (BOEHRINGER INGELHEIM INT [DE], et al); | [Y]WO2017123695 (BOEHRINGER INGELHEIM INT [DE], et al); | [Y]WO2019089512 (LILLY CO ELI [US]) | by applicant | WO2015079417 |